Chemokine oligomerization in cell signaling and migration

Progress in Molecular Biology and Translational Science

Volumn 117, Issue , 2013, Pages 531-578

  Wang, Xu ^a   Sharp, Joshua S ^b   Handel, Tracy M ^c   Prestegard, James H ^b  

^a ARIZONA STATE UNIVERSITY   (United States)

^b UNIVERSITY OF GEORGIA   (United States)

^c UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

Cell migration; Chemokine; Chemokine receptor; Glycosaminoglycan; Mass spectrometry; Nuclear magnetic resonance; Oligomerization; Small angle X ray scattering; Structure

Indexed keywords

CHEMOKINE; DIMER; FRACTALKINE; GAG PROTEIN; GLYCOSAMINOGLYCAN; HYDROXYL RADICAL; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MONOCYTE CHEMOTACTIC PROTEIN 1; MONOCYTE CHEMOTACTIC PROTEIN 3; OLIGOMER; RANTES;

ANIMAL; ARTICLE; CELL MIGRATION; CELL MOTION; CHEMICAL STRUCTURE; CHEMISTRY; CONFORMATIONAL TRANSITION; CRYSTALLIZATION; HUMAN; INTRACELLULAR SIGNALING; METABOLISM; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; NUCLEAR OVERHAUSER EFFECT; OLIGOMERIZATION; PROTEIN BINDING; PROTEIN FOOTPRINTING; PROTEIN MULTIMERIZATION; PROTEIN PROTEIN INTERACTION; PROTEIN QUATERNARY STRUCTURE; PROTEIN TERTIARY STRUCTURE; SIGNAL TRANSDUCTION;

EID: 84896704838     PISSN: 18771173     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-12-386931-9.00020-9     Document Type: Chapter

References (176)

1. D.S. Goodsell, and A.J. Olson Structural symmetry and protein function Annu Rev Biophys Biomol Struct 29 2000 105 153
2. E.D. Levy, J.B. Pereira-Leal, C. Chothia, and S.A. Teichmann 3D complex: a structural classification of protein complexes PLoS Comput Biol 2 11 2006 1395 1406
3. M.H. Ali, and B. Imperiali Protein oligomerization: how and why Bioorg Med Chem 13 17 2005 5013 5020
4. F. Sallusto, and M. Baggiolini Chemokines and leukocyte traffic Nat Immunol 9 9 2008 949 952
5. M. Baggiolini Chemokines and leukocyte traffic Nature 392 6676 1998 565 568
6. D.J. Scholten, M. Canals, and D. Maussang Pharmacological modulation of chemokine receptor function Br J Pharmacol 165 6 2012 1617 1643
7. K. Bacon, M. Baggiolini, and H. Broxmeyer Chemokine/chemokine receptor nomenclature J Interferon Cytokine Res 22 10 2002 1067 1068
8. A. Mantovani The chemokine system: redundancy for robust outputs Immunol Today 20 6 1999 254 257
9. M.N. Devalaraja, and A. Richmond Multiple chemotactic factors: fine control or redundancy? Trends Pharmacol Sci 20 4 1999 151 156
10. Z. Johnson, A.E. Proudfoot, and T.M. Handel Interaction of chemokines and glycosaminoglycans: a new twist in the regulation of chemokine function with opportunities for therapeutic intervention Cytokine Growth Factor Rev 16 6 2005 625 636
11. D. Raman, T. Sobolik-Delmaire, and A. Richmond Chemokines in health and disease Exp Cell Res 317 5 2011 575 589
12. M.Z. Li, J.S. Hale, J.N. Rich, R.M. Ransohoff, and J.D. Lathia Chemokine CXCL12 in neurodegenerative diseases: an SOS signal for stem cell-based repair Trends Neurosci 35 10 2012 619 628
13. A. Tuttolomondo, D. Di Raimondo, R. Pecoraro, V. Arnao, A. Pinto, and G. Licata Atherosclerosis as an inflammatory disease Curr Pharm Des 18 28 2012 4266 4288
14. C. Gerard, and B.J. Rollins Chemokines and disease Nat Immunol 2 2 2001 108 115
15. K.W. Christopherson 2nd., and R.A. Hromas Endothelial chemokines in autoimmune disease Curr Pharm Des 10 2 2004 145 154
16. M. O'Hayre, C.L. Salanga, T.M. Handel, and S.J. Allen Chemokines and cancer: migration, intracellular signalling and intercellular communication in the microenvironment Biochem J 409 2008 635 649
17. C.B. Wilen, J.C. Tilton, and R.W. Doms HIV: cell binding and entry Cold Spring Harb Perspect Med 2 8 2012 1 13
18. C.B. Wilen, J.C. Tilton, and R.W. Doms Molecular mechanisms of HIV entry Adv Exp Med Biol 726 2012 223 242
19. T.J. Schall, and A.E. Proudfoot Overcoming hurdles in developing successful drugs targeting chemokine receptors Nat Rev Immunol 11 5 2011 355 363
20. T.A. Springer Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm Cell 76 2 1994 301 314
21. T.A. Springer Traffic signals on endothelium for lymphocyte recirculation and leukocyte emigration Annu Rev Physiol 57 1995 827 872
22. A.E.I. Proudfoot, T.M. Handel, and Z. Johnson Glycosaminoglycan binding and oligomerization are essential for the in vivo activity of certain chemokines Proc Natl Acad Sci USA 100 4 2003 1885 1890
23. K. Rajarathnam, B.D. Sykes, and C.M. Kay Neutrophil activation by monomeric interleukin-8 Science 264 5155 1994 90 92
24. C.D. Paavola, S. Hemmerich, and D. Grunberger Monomeric monocyte chemoattractant protein-1 (MCP-1) binds and activates the MCP-1 receptor CCR2B J Biol Chem 273 50 1998 33157 33165
25. C. Blanpain, B.J. Doranz, and A. Bondue The core domain of chemokines binds CCR5 extracellular domains while their amino terminus interacts with the transmembrane helix bundle J Biol Chem 278 7 2003 5179 5187
26. B. Stephens, and T.M. Handel Chemokine receptor oligomerization and allostery Prog in Mol Biol Transl Sci 115 2013 375 420
27. C.T. Veldkamp, C. Seibert, and F.C. Peterson Structural basis of CXCR4 sulfotyrosine recognition by the chemokine SDF-1/CXCL12 Sci Signal 1 37 2008 ra4
28. L. Duma, D. Haussinger, M. Rogowski, P. Lusso, and S. Grzesiek Recognition of RANTES by extracellular parts of the CCR5 receptor J Mol Biol 365 4 2007 1063 1075
29. A.J. Hoogewerf, G.S. Kuschert, and A.E. Proudfoot Glycosaminoglycans mediate cell surface oligomerization of chemokines Biochemistry 36 44 1997 13570 13578
30. G.S. Campanella, J. Grimm, and L.A. Manice Oligomerization of CXCL10 is necessary for endothelial cell presentation and in vivo activity J Immunol 177 10 2006 6991 6998
31. J.I. Ellyard, L. Simson, A. Bezos, K. Johnston, C. Freeman, and C.R. Parish Eotaxin selectively binds heparin. An interaction that protects eotaxin from proteolysis and potentiates chemotactic activity in vivo J Biol Chem 282 20 2007 15238 15247
32. T. Baltus, K.S. Weber, Z. Johnson, A.E. Proudfoot, and C. Weber Oligomerization of RANTES is required for CCR1-mediated arrest but not CCR5-mediated transmigration of leukocytes on inflamed endothelium Blood 102 6 2003 1985 1988
33. L. Wang, M. Fuster, P. Sriramarao, and J.D. Esko Endothelial heparan sulfate deficiency impairs L-selectin- and chemokine-mediated neutrophil trafficking during inflammatory responses Nat Immunol 6 9 2005 902 910
34. X. Yin, J. Truty, and R. Lawrence A critical role for lymphatic endothelial heparan sulfate in lymph node metastasis Mol Cancer 9 2010 316
35. L.J. Drury, J.J. Ziarek, and S. Gravel Monomeric and dimeric CXCL12 inhibit metastasis through distinct CXCR4 interactions and signaling pathways Proc Natl Acad Sci USA 108 43 2011 17655 17660
36. V. Appay, P.R. Dunbar, V. Cerundolo, A. McMichael, L. Czaplewski, and S. Rowland-Jones RANTES activates antigen-specific cytotoxic T lymphocytes in a mitogen-like manner through cell surface aggregation Int Immunol 12 8 2000 1173 1182
37. B. Roscic-Mrkic, M. Fischer, and C. Leemann RANTES (CCL5) uses the proteoglycan CD44 as an auxiliary receptor to mediate cellular activation signals and HIV-1 enhancement Blood 102 4 2003 1169 1177
38. L. Wagner, O.O. Yang, and E.A. Garcia-Zepeda Beta-chemokines are released from HIV-1-specific cytolytic T-cell granules complexed to proteoglycans Nature 391 6670 1998 908 911
39. B.L. Wu, E.Y.T. Chien, and C.D. Mol Structures of the CXCR4 chemokine GPCR with small-molecule and cyclic peptide antagonists Science 330 6007 2010 1066 1071
40. B.K. Kramp, A. Sarabi, R.R. Koenen, and C. Weber Heterophilic chemokine receptor interactions in chemokine signaling and biology Exp Cell Res 317 5 2011 655 663
41. P. von Hundelshausen, R.R. Koenen, and M. Sack Heterophilic interactions of platelet factor 4 and RANTES promote monocyte arrest on endothelium Blood 105 3 2005 924 930
42. R.R. Koenen, P. von Hundelshausen, and I.V. Nesmelova Disrupting functional interactions between platelet chemokines inhibits atherosclerosis in hyperlipidemic mice Nat Med 15 1 2009 97 103
43. S. Shahrara, A.E. Proudfoot, and C.C. Park Inhibition of monocyte chemoattractant protein-1 ameliorates rat adjuvant-induced arthritis J Immunol 180 5 2008 3447 3456
44. A.E. Proudfoot, C.A. Power, C. Rommel, and T.N. Wells Strategies for chemokine antagonists as therapeutics Semin Immunol 15 1 2003 57 65
45. Z. Johnson, M.H. Kosco-Vilbois, and S. Herren Interference with heparin binding and oligomerization creates a novel anti-inflammatory strategy targeting the chemokine system J Immunol 173 9 2004 5776 5785
46. S.J. Allen, S.E. Crown, and T.M. Handel Chemokine: receptor structure, interactions, and antagonism Annu Rev Immunol 25 2007 787 820
47. E.J. Fernandez, and E. Lolis Structure junction, and inhibition of chemokines Annu Rev Pharmacol 42 2002 469 499
48. W.J. Fairbrother, D. Reilly, T.J. Colby, J. Hesselgesser, and R. Horuk The solution structure of melanoma growth-stimulating activity J Mol Biol 242 3 1994 252 270
49. Y.Q. Qian, K.O. Johanson, and P. McDevitt Nuclear magnetic resonance solution structure of truncated human GRO beta [5-73] and its structural comparison with CXC chemokine family members GRO alpha and IL-8 J Mol Biol 294 5 1999 1065 1072
50. K.H. Mayo, V. Roongta, and E. Ilyina NMR solution structure of the 32-Kda platelet factor-4 Elr-motif N-terminal chimera - a symmetrical tetramer Biochemistry 34 36 1995 11399 11409
51. X.H. Zhang, L.Q. Chen, D.P. Bancroft, C.K. Lai, and T.E. Maione Crystal-structure of recombinant human platelet factor-4 Biochemistry 33 27 1994 8361 8366
52. M.G. Malkowski, J.Y. Wu, J.B. Lazar, P.H. Johnson, and B.F.P. Edwards The crystal-structure of recombinant human neutrophil-activating peptide-2 (M6l) at 1.9-Angstrom resolution J Biol Chem 270 13 1995 7077 7087
53. H. Young, V. Roongta, T.J. Daly, and K.H. Mayo NMR structure and dynamics of monomeric neutrophil-activating peptide 2 Biochem J 338 1999 591 598
54. G.M. Clore, E. Appella, M. Yamada, K. Matsushima, and A.M. Gronenborn 3-Dimensional structure of Interleukin-8 in solution Biochemistry 29 7 1990 1689 1696
55. G.J. Swaminathan, D.E. Holloway, and R.A. Colvin Crystal structures of oligomeric forms of the IP-10/CXCL10 chemokine Structure 11 5 2003 521 532
56. V. Booth, I. Clark-Lewis, and B.D. Sykes NMR structure of CXCR3 binding chemokine CXCL11 (ITAC) Protein Sci 13 8 2004 2022 2028
57. C. Dealwis, E.J. Fernandez, D.A. Thompson, R.J. Simon, M.A. Siani, and E. Lolis Crystal structure of chemically synthesized [N33A] stromal cell-derived factor 1 alpha, a potent ligand for the HIV-1 "fusin" coreceptor Proc Natl Acad Sci USA 95 12 1998 6941 6946
58. M.P. Crump, J.H. Gong, and P. Loetscher Solution structure and basis for functional activity of stromal cell-derived factor-1; dissociation of CXCR4 activation from binding and inhibition of HIV-1 EMBO J 16 23 1997 6996 7007
59. D.W. Keizer, M.P. Crump, T.W. Lee, C.M. Slupsky, I. Clark-Lewis, and B.D. Sykes Human CC chemokine I-309, structural consequences of the additional disulfide bond Biochemistry 39 20 2000 6053 6059
60. T.M. Handel, and P.J. Domaille Heteronuclear (H-1, C-13, N-15) NMR assignments and solution structure of the monocyte chemoattractant protein-1 (MCP-1) dimer Biochemistry 35 21 1996 6569 6584
61. J. Lubkowski, G. Bujacz, L. Boque, P.J. Domaille, T.M. Handel, and A. Wlodawer The structure of MCP-1 in two crystal forms provides a rare example of variable quaternary interactions Nat Struct Biol 4 1 1997 64 69
62. L.G. Czaplewski, J. McKeating, and C.J. Craven Identification of amino acid residues critical for aggregation of human CC chemokines macrophage inflammatory protein (MIP)-1 alpha, MIP-1 beta, and RANTES - Characterization of active disaggregated chemokine variants J Biol Chem 274 23 1999 16077 16084
63. P.J. Lodi, D.S. Garrett, and J. Kuszewski High-resolution solution structure of the beta-chemokine hMIP-1-beta by multidimensional NMR Science 263 5154 1994 1762 1767
64. C.W. Chung, R.M. Cooke, A.E.I. Proudfoot, and T.N.C. Wells The 3-dimensional solution structure of RANTES Biochemistry 34 29 1995 9307 9314
65. K.S. Kim, K. Rajarathnam, I. ClarkLewis, and B.D. Sykes Structural characterization of a monomeric chemokine: monocyte chemoattractant protein-3 FEBS Lett 395 2-3 1996 277 282
66. J. Blaszczyk, E. Van Coillie, and P. Proost Complete crystal structure of monocyte chemotactic protein-2, a CC chemokine that interacts with multiple receptors Biochemistry 39 46 2000 14075 14081
67. M.P. Crump, K. Rajarathnam, K.S. Kim, I. Clark-Lewis, and B.D. Sykes Solution structure of eotaxin, a chemokine that selectively recruits eosinophils in allergic inflammation J Biol Chem 273 35 1998 22471 22479
68. C. Barinka, A. Prahl, and J. Lubkowski Structure of human monocyte chemoattractant protein 4 (MCP-4/CCL13) Acta Crystallogr D Biol Crystallogr 64 2008 273 278
69. K.Y. Blain, W. Kwiatkowski, and Q. Zhao Structural and functional characterization of CC chemokine CCL14 Biochemistry 46 35 2007 10008 10015
70. H. Sticht, S.E. Escher, K. Schweimer, W.G. Forssmann, P. Rosch, and K. Adermann Solution structure of the human CC chemokine 2: a monomeric representative of the CC chemokine subtype Biochemistry 38 19 1999 5995 6002
71. O.A. Asojo, C. Boulegue, D.M. Hoover, W.Y. Lu, and J. Lubkowski Structures of thymus and activation-regulated chemokine (TARC) Acta Crystallogr D Biol Crystallogr 59 2003 1165 1173
72. M. Love, J.L. Sandberg, and J.J. Ziarek Solution Structure of CCL21 and Identification of a Putative CCR7 Binding Site Biochemistry 51 3 2012 733 735
73. K. Rajarathnam, Y.L. Li, T. Rohrer, and R. Gentz Solution structure and dynamics of myeloid progenitor inhibitory factor-1 (MPIF-1), a novel monomeric CC chemokine J Biol Chem 276 7 2001 4909 4916
74. K.L. Mayer, and M.J. Stone NMR solution structure and receptor peptide binding of the CC chemokine eotaxin-2 Biochemistry 39 29 2000 8382 8395
75. J. Ye, K.L. Mayer, M.R. Mayer, and M.J. Stone NMR solution structure and backbone dynamics of the CC chemokine eotaxin-3 Biochemistry 40 26 2001 7820 7831
76. A.L. Jansma, J.P. Kirkpatrick, A.R. Hsu, T.M. Handel, and D. Nietlispach NMR analysis of the structure, dynamics, and unique oligomerization properties of the chemokine CCL27 J Biol Chem 285 19 2010 14424 14437
77. R.L. Tuinstra, F.C. Peterson, S. Kutlesa, E.S. Elgin, M.A. Kron, and B.F. Volkman Interconversion between two unrelated protein folds in the lymphotactin native state Proc Natl Acad Sci USA 105 13 2008 5057 5062
78. L.S. Mizoue, J.F. Bazan, E.C. Johnson, and T.M. Handel Solution structure and dynamics of the CX3C chemokine domain of fractalkine and its interaction with an N-terminal fragment of CX(3)CR1 Biochemistry 38 5 1999 1402 1414
79. D.M. Hoover, L.S. Mizoue, T.M. Handel, and J. Lubkowski The crystal structure of the chemokine domain of fractalkine shows a novel quaternary arrangement J Biol Chem 275 30 2000 23187 23193
80. J.H. Gong, and I. Clarklewis Antagonists of monocyte chemoattractant protein-1 identified by modification of functionally critical NH2-terminal residues J Exp Med 181 2 1995 631 640
81. E. Guan, J.H. Wang, G. Roderiquez, and M.A. Norcross Natural truncation of the chemokine MIP-1 beta/CCL4 affects receptor specificity but not Anti-HIV-1 activity J Biol Chem 277 35 2002 32348 32352
82. A.E.I. Proudfoot, C.A. Power, and A.J. Hoogewerf Extension of recombinant human RANTES by the retention of the initiating methionine produces a potent antagonist J Biol Chem 271 5 1996 2599 2603
83. S.A. Williams, Y. Harata-Lee, I. Comerford, R.L. Anderson, M.J. Smyth, and S.R. McColl Multiple functions of CXCL12 in a syngeneic model of breast cancer Mol Cancer 9 250 2010 1 10
84. H. Gaertner, F. Cerini, and J.M. Escola Highly potent, fully recombinant anti-HIV chemokines: reengineering a low-cost microbicide Proc Natl Acad Sci USA 105 46 2008 17706 17711
85. P. Loetscher, J.H. Gong, B. Dewald, M. Baggiolini, and I. Clark-Lewis N-terminal peptides of stromal cell-derived factor-1 with CXC chemokine receptor 4 agonist and antagonist activities J Biol Chem 273 35 1998 22279 22283
86. J.S. Luo, Z.W. Luo, N.M. Zhou, J.W. Hall, and Z.W. Huang Attachment of C-terminus of SDF-1 enhances the biological activity of its N-terminal peptide Biochem Biophys Res Commun 264 1 1999 42 47
87. D.R. Pakianathan, E.G. Kuta, D.R. Artis, N.J. Skelton, and C.A. Hebert Distinct but overlapping epitopes for the interaction of a CC-chemokine with CCR1, CCR3, and CCR5 Biochemistry 36 32 1997 9642 9648
88. I. Clarklewis, B. Dewald, M. Loetscher, B. Moser, and M. Baggiolini Structural requirements for interleukin-8 function identified by design of analogs and CXC chemokine hybrids J Biol Chem 269 23 1994 16075 16081
89. H.B. Lowman, P.H. Slagle, and L.E. DeForge Exchanging interleukin-8 and melanoma growth-stimulating activity receptor binding specificities J Biol Chem 271 24 1996 14344 14352
90. C.J. Beall, S. Mahajan, D.E. Kuhn, and P.E. Kolattukudy Site-directed mutagenesis of monocyte chemoattractant protein-1 identifies two regions of the polypeptide essential for biological activity Biochem J 313 1996 633 640
91. S. Hemmerich, C. Paavola, and A. Bloom Identification of residues in the monocyte chemotactic protein-1 that contact the MCP-1 receptor, CCR2 Biochemistry 38 40 1999 13013 13025
92. L. Martin, C. Blanpain, P. Garnier, V. Wittamer, M. Parmentier, and C. Vita Structural and functional analysis of the RANTES-glycosaminoglycans interactions Biochemistry 40 21 2001 6303 6318
93. A.E.I. Proudfoot, S. Fritchley, and F. Borlat The BBXB motif of RANTES is the principal site for heparin binding and controls receptor selectivity J Biol Chem 276 14 2001 10620 10626
94. C. Yoshiura, Y. Kofuku, and T. Ueda NMR Analyses of the Interaction between CCR5 and Its Ligand Using Functional Reconstitution of CCR5 in Lipid Bilayers J Am Chem Soc 132 19 2010 6768 6777
95. R.M. Strieter, M.D. Burdick, B.N. Gomperts, J.A. Belperio, and M.P. Keane CXC chemokines in angiogenesis Cytokine Growth Factor Rev 16 6 2005 593 609
96. S. Ali, G. O'Boyle, P. Hepplewhite, J.R. Tyler, H. Robertson, and J.A. Kirby Therapy with nonglycosaminoglycan-binding mutant CCL7: a novel strategy to limit allograft inflammation Am J Transplant 10 1 2010 47 58
97. E.K. Lau, C.D. Paavola, and Z. Johnson Identification of the glycosaminoglycan binding site of the CC chemokine, MCP-1 - Implications for structure and function in vivo J Biol Chem 279 21 2004 22294 22305
98. T. Jabeen, P. Leonard, H. Jamaluddin, and K.R. Acharya Structure of mouse IP-10, a chemokine Acta Crystallogr D Biol Crystallogr 64 2008 611 619
99. J.W. Murphy, H. Yuan, Y. Kong, Y. Xiong, and E.J. Lolis Heterologous quaternary structure of CXCL12 and its relationship to the CC chemokine family Proteins 78 5 2010 1331 1337
100. X. Wang, C. Watson, J.S. Sharp, T.M. Handel, and J.H. Prestegard Oligomeric structure of the chemokine CCL5/RANTES from NMR, MS, and SAXS data Structure 19 8 2011 1138 1148
101. M. Ren, Q. Guo, and L.A. Guo Polymerization of MIP-1 chemokine (CCL3 and CCL4) and clearance of MIP-1 by insulin-degrading enzyme EMBO J 29 23 2010 3952 3966
102. R.I. Handin, and H.J. Cohen Purification and binding properties of human platelet factor 4 J Biol Chem 251 14 1976 4273 4282
103. T.M. Handel, Z. Johnson, S.E. Crown, E.K. Lau, M. Sweeney, and A.E. Proudfoot Regulation of protein function by glycosaminoglycans - as exemplified by chemokines Annu Rev Biochem 74 2005 385 410
104. G.S.V. Kuschert, F. Coulin, and C.A. Power Glycosaminoglycans interact selectively with chemokines and modulate receptor binding and cellular responses Biochemistry 38 39 1999 12959 12968
105. A. Amara, O. Lorthioir, and A. Valenzuela Stromal cell-derived factor-1 alpha associates with heparan sulfates through the first beta-strand of the chemokine J Biol Chem 274 34 1999 23916 23925
106. W. Koopmann, and M.S. Krangel Identification of a glycosaminoglycan- binding site in chemokine macrophage inflammatory protein-1 alpha J Biol Chem 272 15 1997 10103 10109
107. R. Sadir, F. Baleux, A. Grosdidier, A. Imberty, and H. Lortat-Jacob Characterization of the stromal cell-derived factor-l alpha-heparin complex J Biol Chem 276 11 2001 8288 8296
108. K. Jarnagin, D. Grunberger, and M. Mulkins Identification of surface residues of the monocyte chemotactic protein 1 that affect signaling through the receptor CCR2 Biochemistry 38 49 1999 16167 16177
109. C.L. Salanga, and T.M. Handel Chemokine oligomerization and interactions with receptors and glycosaminoglycans: the role of structural dynamics in function Exp Cell Res 317 5 2011 590 601
110. D. Spillmann, D. Witt, and U. Lindahl Defining the interleukin-8-binding domain of heparan sulfate J Biol Chem 273 25 1998 15487 15493
111. A. Rek, B. Brandner, E. Geretti, and A.J. Kungl A biophysical insight into the RANTES-glycosaminoglycan interaction Biochim Biophys Acta 1794 4 2009 577 582
112. S.E. Stringer, M.J. Forster, B. Mulloy, C.R. Bishop, G.J. Graham, and J.T. Gallagher Characterization of the binding site on heparan sulfate for macrophage inflammatory protein 1 alpha Blood 100 5 2002 1543 1550
113. S. Kim, S. Jao, J.S. Laurence, and P.J. LiWang Structural comparison of monomeric variants of the chemokine MIP-1 beta having differing ability to bind the receptor CCR5 Biochemistry 40 36 2001 10782 10791
114. S. Meunier, J.M. Bernassau, J.C. Guillemot, P. Ferrara, and H. Darbon Determination of the three-dimensional structure of CC chemokine monocyte chemoattractant protein 3 by H-1 two-dimensional NMR spectroscopy Biochemistry 36 15 1997 4412 4422
115. N.J. Skelton, F. Aspiras, J. Ogez, and T.J. Schall Proton NMR assignments and solution conformation of RANTES, a chemokine of the C-C type Biochemistry 34 16 1995 5329 5342
116. C.T. Veldkamp, J.J. Ziarek, and J.D. Su Monomeric structure of the cardioprotective chemokine SDF-1/CXCL12 Protein Sci 18 7 2009 1359 1369
117. B.F. Volkman, T.Y. Liu, and F.C. Peterson Lymphotactin structural dynamics T.M. Handel, D.J. Hamel, Chemokines, Part B Methods in enzymology vol. 461 2009 Elsevier 51 70
118. B. Zhao, and P.J. LiWang Characterization of the Interactions of vMIP-II, and a Dimeric Variant of vMIP-II, with Glycosaminoglycans Biochemistry 49 33 2010 7012 7022
119. I. Shimada, T. Ueda, and M. Matsumoto Cross-saturation and transferred cross-saturation experiments Prog Nucl Magn Reson Spectrosc 54 2 2009 123 140
120. T.H. Bayburt, and S.G. Sligar Membrane protein assembly into Nanodiscs FEBS Lett 584 9 2010 1721 1727
121. N.J. Greenfield, Y.J. Huang, and T. Palm Solution NMR structure and folding dynamics of the N terminus of a rat non-muscle alpha-tropomyosin in an engineered chimeric protein J Mol Biol 312 4 2001 833 847
122. A. Bax, G. Kontaxis, and N. Tjandra Dipolar couplings in macromolecular structure determination. Nuclear Magnetic Resonance of Biological Macromolecules, Part B Meth Enzymol 339 2001 127 174
123. J.H. Prestegard, C.M. Bougault, and A.I. Kishore Residual dipolar couplings in structure determination of biomolecules Chem Rev 104 8 2004 3519 3540
124. H.W. Lee, G. Wylie, and S. Bansal Three-dimensional structure of the weakly associated protein homodimer SeR13 using RDCs and paramagnetic surface mapping Protein Sci 19 9 2010 1673 1685
125. X. Wang, H.W. Lee, Y.Z. Liu, and J.H. Prestegard Structural NMR of protein oligomers using hybrid methods J Struct Biol 173 3 2011 515 529
126. X. Wang, S. Bansal, M. Jiang, and J.H. Prestegard RDC-assisted modeling of symmetric protein homo-oligomers Protein Sci 17 5 2008 899 907
127. J.P. Shaw, G. Kryger, and A. Cleasby Crystallization and preliminary-X-ray diffraction studies of human RANTES J Mol Biol 242 4 1994 589 590
128. Y.Z. Liu, and J.H. Prestegard A device for the measurement of residual chemical shift anisotropy and residual dipolar coupling in soluble and membrane-associated proteins J Biomol NMR 47 4 2010 249 258
129. F. Yu, J.J. Wolff, I.J. Amster, and J.H. Prestegard Conformational preferences of chondroitin sulfate oligomers using partially oriented NMR spectroscopy of C-13-labeled acetyl groups J Am Chem Soc 129 43 2007 13288 13297
130. E. Gemma, A.N. Hulme, and A. Jahnke DMT-MM mediated functionalisation of the non-reducing end of glycosaminoglycans Chem Commun 26 2007 2686 2688
131. B.S. Blaum, J.A. Deakin, and C.M. Johansson Lysine and arginine side chains in glycosaminoglycan-protein complexes Investigated by NMR, cross-linking, and mass spectrometry: a case study of the factor H-heparin Interaction J Am Chem Soc 132 18 2010 6374 6381
132. V. Roldos, F.J. Canada, and J. Jimenez-Barbero Carbohydrate-protein interactions: a 3D View by NMR Chembiochem 12 2011 990 1005 12(9):CP27-CP27
133. B. Meyer, and T. Peters NMR Spectroscopy techniques for screening and identifying ligand binding to protein receptors Angew Chem Int Ed 42 8 2003 864 890
134. C. Laguri, N. Sapay, and J.P. Simorre C-13-labeled heparan sulfate analogue as a tool to study protein/heparan sulfate interactions by NMR spectroscopy: application to the CXCL12 alpha chemokine J Am Chem Soc 133 25 2011 9642 9645
135. 2O J Biol Chem 269 5 1994 3331 3338
136. M. Hricovini, M. Guerrini, A. Bisio, G. Torri, M. Petitou, and B. Casu Conformation of heparin pentasaccharide bound to antithrombin III Biochem J 359 2001 265 272
137. S.C. Tjong, T.S. Chen, W.N. Huang, and W.G. Wu Structures of heparin-derived tetrasaccharide bound to cobra cardiotoxins: heparin binding at a single protein site with diverse side chain interactions Biochemistry 46 35 2007 9941 9952
138. H.J. Zhou, J.R. Casas-Finet, and R.H. Coats Identification and dynamics of a heparin-binding site in hepatocyte growth factor Biochemistry 38 45 1999 14793 14802
139. F.J. Moy, M. Safran, and A.P. Seddon Properly oriented heparin-decasaccharide-induced dimers are the biologically active form of basic fibroblast growth factor Biochemistry 36 16 1997 4782 4791
140. Boons GJ. Modular synthesis of heparan sulfate oligosaccharides for array development. Abstracts of Papers of the American Chemical Society. Aug 2010. p. 240.
141. S.S. Deepa, S. Yamada, S. Fukui, and K. Sugahara Structural determination of novel sulfated octasaccharides isolated from chondroitin sulfate of shark cartilage and their application for characterizing monoclonal antibody epitopes Glycobiology 17 6 2007 631 645
142. V.H. Pomin, Y. Park, and R.R. Huang Exploiting enzyme specificities in digestions of chondroitin sulfates A and C: production of well-defined hexasaccharides Glycobiology 22 6 2012 826 838
143. P.L. DeAngelis Glycosaminoglycan polysaccharide biosynthesis and production: today and tomorrow Appl Microbiol Biotechnol 94 2 2012 295 305
144. B. Casu, G. Grazioli, and N. Razi Heparin-like compounds prepared by chemical modification of capsular polysaccharide from Escherichia-coli K5 Carbohydr Res 263 2 1994 271 284
145. K. Nagasawa, H. Uchiyama, and N. Wajima Chemical sulfation of preparations of chondroitin 4-sulfate and 6-sulfate, and dermatan sulfate - preparation of chondroitin sulfate E-Like materials from chondroitin 4-sulfate Carbohydr Res 158 1986 183 190
146. P.L. DeAngelis, W. Jing, B.S. Tracy, L.C. Oatman, and D.F. Gay Chemoenzymatic synthesis of glycosaminoglycans with pasteurella synthases Glycobiology 13 11 2003 838 839
147. P.L. DeAngelis, L.C. Oatman, and D.F. Gay Rapid chemoenzymatic synthesis of monodisperse hyaluronan oligosaccharides with immobilized enzyme reactors J Biol Chem 278 37 2003 35199 35203
148. W. Jing, F.M. Haller, A. Almond, and P.L. DeAngelis Defined megadalton hyaluronan polymer standards Anal Biochem 355 2 2006 183 188
149. Y.M. Xu, S. Masuko, and M. Takieddin Chemoenzymatic synthesis of homogeneous ultralow molecular weight heparins Science 334 6055 2011 498 501
150. M. Mobli, M. Nilsson, and A. Almond The structural plasticity of heparan sulfate NA-domains and hence their role in mediating multivalent interactions is confirmed by high-accuracy (15)N-NMR relaxation studies Glycoconj J 25 5 2008 401 414
151. V.H. Pomin, J.S. Sharp, X.Y. Li, L.C. Wang, and J.H. Prestegard Characterization of glycosaminoglycans by N-15 NMR spectroscopy and in vivo isotopic labeling Anal Chem 82 10 2010 4078 4088
152. C.D. Putnam, M. Hammel, G.L. Hura, and J.A. Tainer X-ray solution scattering (SAXS) combined with crystallography and computation: defining accurate macromolecular structures, conformations and assemblies in solution Q Rev Biophys 40 3 2007 191 285
153. D.I. Svergun Small-angle X-ray and neutron scattering as a tool for structural systems biology Biol Chem 391 7 2010 737 743
154. A.A. Rostom, and C.V. Robinson Disassembly of intact multiprotein complexes in the gas phase Curr Opin Struct Biol 9 1 1999 135 141
155. F. Sobott, H. Hernandez, M.G. McCammon, M.A. Tito, and C.V. Robinson A tandem mass spectrometer for improved transmission and analysis of large macromolecular assemblies Anal Chem 74 6 2002 1402 1407
156. E.W. Chung, D.A. Henriques, and D. Renzoni Probing the nature of interactions in SH2 binding interfaces - evidence from electrospray ionization mass spectrometry Protein Sci 8 10 1999 1962 1970
157. Y. Yu, M.D. Sweeney, and O.M. Saad Chemokine-glycosaminoglycan binding: specificity for CCR2 ligand binding to highly sulfated oligosaccharides using FTICR mass spectrometry J Biol Chem 280 37 2005 32200 32208
158. S.E. Crown, Y. Yu, M.D. Sweeney, J.A. Leary, and T.M. Handel Heterodimerization of CCR2 chemokines and regulation by glycosaminoglycan binding J Biol Chem 281 35 2006 25438 25446
159. J. Carlson, S.A. Baxter, D. Dreau, and I.V. Nesmelova The heterodimerization of platelet-derived chemokines Biochim Biophys Acta 1834 1 2012 158 168
160. J.S. Sharp, J.M. Becker, and R.L. Hettich Protein surface mapping by chemical oxidation: structural analysis by mass spectrometry Anal Biochem 313 2 2003 216 225
161. J.S. Sharp, J.M. Becker, and R.L. Hettich Topology characterization of model proteins by photochemical side chain oxidation and mass spectrometry FASEB J 17 5 2003 A988
162. D.M. Hambly, and M.L. Gross Laser flash photolysis of hydrogen peroxide to oxidize protein solvent-accessible residues on the microsecond timescale J Am Soc Mass Spectrom 16 12 2005 2057 2063
163. C. McClintock, V. Kertesz, and R.L. Hettich Development of an electrochemical oxidation method for probing higher order protein structure with mass spectrometry Anal Chem 80 9 2008 3304 3317
164. S.D. Maleknia, M.R. Chance, and K.M. Downard Electrospray-assisted modification of proteins: a radical probe of protein structure Rapid Commun Mass Spectrom 13 23 1999 2352 2358
165. S.D. Maleknia, M. Brenowitz, and M.R. Chance Millisecond radiolytic modification of peptides by synchrotron X-rays identified by mass spectrometry Anal Chem 71 18 1999 3965 3973
166. J.S. Sharp, D.M. Sullivan, J. Cavanagh, and K.B. Tomer Measurement of multisite oxidation kinetics reveals an active site conformational change in Spo0F as a result of protein oxidation Biochemistry 45 20 2006 6260 6266
167. C. Watson, I. Janik, T. Zhuang, O. Charvatova, R.J. Woods, and J.S. Sharp Pulsed electron beam water radiolysis for submicrosecond hydroxyl radical protein footprinting Anal Chem 81 7 2009 2496 2505
168. G.V. Buxton, C.L. Greenstock, W.P. Helman, and A.B. Ross Critical-review of rate constants for reactions of hydrated electrons, hydrogen-atoms and hydroxyl radicals (.Oh/.O-) in aqueous-solution J Phys Chem Ref Data 17 2 1988 513 886
169. G. Xu, and M.R. Chance Radiolytic modification and reactivity of amino acid residues serving as structural probes for protein footprinting Anal Chem 77 14 2005 4549 4555
170. M.R. Chance Unfolding of apomyoglobin examined by synchrotron footprinting Biochem Biophys Res Commun 287 3 2001 614 621
171. O. Charvatova, B.L. Foley, M.W. Bern, J.S. Sharp, R. Orlando, and R.J. Woods Quantifying protein interface footprinting by hydroxyl radical oxidation and molecular dynamics simulation: application to galectin-1 J Am Soc Mass Spectrom 19 11 2008 1692 1705
172. J.Q. Guan, S. Vorobiev, S.C. Almo, and M.R. Chance Mapping the G-actin binding surface of cofilin using synchrotron protein footprinting Biochemistry 41 18 2002 5765 5775
173. B.C. Gau, J.S. Sharp, D.L. Rempel, and M.L. Gross Fast photochemical oxidation of protein footprints faster than protein unfolding Anal Chem 81 16 2009 6563 6571
174. C. Watson, and J.S. Sharp Conformational analysis of therapeutic proteins by hydroxyl radical protein footprinting AAPS J 14 2 2012 206 217
175. S. Vahidi, B.B. Stocks, Y. Liaghati-Mobarhan, and L. Konermann Mapping pH-induced protein structural changes under equilibrium conditions by pulsed oxidative labeling and mass spectrometry Anal Chem 84 21 2012 9124 9130
176. H.J. Jin, I. Kagiampakis, P.W. Li, and P.J. LiWang Structural and functional studies of the potent anti-HIV chemokine variant P2-RANTES Proteins 78 2 2010 295 308